INTS vs NFLX · $7.7M cap vs P/E 25, rev $45.18B
Intensity Therapeutics, Inc. Common stock (INTS) versus Netflix Inc (NFLX) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Netflix Inc (NFLX) is a entertainment company listed on NASDAQ. It is led by Ted Sarandos.
INTS does not have a complete income-statement cache yet.
Latest reported NFLX revenue for 2025-12-31 was $45.18B. Net income was $10.98B. Revenue was up 15.9% from 2024-12-31 to 2025-12-31. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
INTS currently screens at market cap $7.7M. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
Not investment advice. Open the INTS and NFLX stock pages for the full models.
Not investment advice.